Different Lung Ultrasound Imaging Protocols in COVID-19 Pneumonia
NCT ID: NCT04805684
Last Updated: 2021-03-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
59 participants
INTERVENTIONAL
2021-01-01
2021-03-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lung Ultrasonography in COVID-19 Pneumonia
NCT04719234
Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study
NCT04338568
Correlation Between Thoracic Ultrasound and Thorax Computed Tomography Scores.
NCT04577235
The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19
NCT04399681
Lung Ultrasound for COVID-19 Initial Triage and Monitoring
NCT04474236
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
lung ultrasound 12
12 zone lung ultrasonography protocol
LUS Twelve area
Application of 12 areas (2 posterior, 2 lateral, and 2 anterior)lung ultrasonography protocol using the convex ultrasound probe (2-6 MHz)
lung ultrasound 14
14 zone lung ultrasonography protocol
LUS Fourteen area
Application of 14 areas (3 posterior, 2 lateral, and 2 anterior) lung ultrasonography protocol using the convex ultrasound probe (2-6 MHz)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LUS Twelve area
Application of 12 areas (2 posterior, 2 lateral, and 2 anterior)lung ultrasonography protocol using the convex ultrasound probe (2-6 MHz)
LUS Fourteen area
Application of 14 areas (3 posterior, 2 lateral, and 2 anterior) lung ultrasonography protocol using the convex ultrasound probe (2-6 MHz)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hospitalized in intensive care unit
* PCR (polymerase chain reaction) tested
* Thoracic CT applied
Exclusion Criteria
* Thoracic wall disorder
* Interstitial lung disease
* Patients who did not consent to participate in the study
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bursa Yuksek Ihtisas Training and Research Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Korgün Ökmen
Principal Investigator ,Assoc. PhD. M.D.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital
Bursa, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011-KAEK-25 2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.